JP2004535795A5 - - Google Patents

Download PDF

Info

Publication number
JP2004535795A5
JP2004535795A5 JP2002589630A JP2002589630A JP2004535795A5 JP 2004535795 A5 JP2004535795 A5 JP 2004535795A5 JP 2002589630 A JP2002589630 A JP 2002589630A JP 2002589630 A JP2002589630 A JP 2002589630A JP 2004535795 A5 JP2004535795 A5 JP 2004535795A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
amino acid
nucleic acid
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002589630A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004535795A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/014587 external-priority patent/WO2002092762A2/en
Publication of JP2004535795A publication Critical patent/JP2004535795A/ja
Publication of JP2004535795A5 publication Critical patent/JP2004535795A5/ja
Withdrawn legal-status Critical Current

Links

JP2002589630A 2001-05-10 2002-05-08 サイトカインポリペプチド群 Withdrawn JP2004535795A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29023901P 2001-05-10 2001-05-10
PCT/US2002/014587 WO2002092762A2 (en) 2001-05-10 2002-05-08 Cytokine polypeptides

Publications (2)

Publication Number Publication Date
JP2004535795A JP2004535795A (ja) 2004-12-02
JP2004535795A5 true JP2004535795A5 (enExample) 2005-12-22

Family

ID=23115104

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002589630A Withdrawn JP2004535795A (ja) 2001-05-10 2002-05-08 サイトカインポリペプチド群

Country Status (8)

Country Link
US (2) US20030104579A1 (enExample)
EP (1) EP1412499A4 (enExample)
JP (1) JP2004535795A (enExample)
AU (1) AU2002314774B2 (enExample)
CA (1) CA2446180A1 (enExample)
MX (1) MXPA03010181A (enExample)
PL (1) PL373008A1 (enExample)
WO (1) WO2002092762A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2286128T3 (es) 2000-06-30 2007-12-01 Zymogenetics, Inc. Proteina zcyto21 tipo interferon.
US7910313B2 (en) 2001-04-20 2011-03-22 Zymogenetics, Inc. Cytokine protein family
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
WO2002086087A2 (en) * 2001-04-20 2002-10-31 Zymogenetics, Inc. Cytokine protein family
WO2003066002A2 (en) 2002-02-08 2003-08-14 University Of Medicine And Dentistry Of New Jersey IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION
CA2503305A1 (en) 2002-10-23 2004-05-06 Zymogenetics, Inc. Methods for treating viral infection using il-28 and il-29
JP4808157B2 (ja) 2003-08-07 2011-11-02 ザイモジェネティクス リミテッド ライアビリティ カンパニー Il−28およびil−29の均一な調製物
AU2005231476B2 (en) 2004-04-02 2011-09-01 Zymogenetics, Inc. Il-28 and il-29 cysteine mutants for treating viral infection
US7351689B2 (en) 2004-07-29 2008-04-01 Zymogenetics, Inc. Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
US8158129B2 (en) * 2005-04-06 2012-04-17 Ibc Pharmaceuticals, Inc. Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo
EP1909821A2 (en) 2005-07-20 2008-04-16 ZymoGenetics, Inc. Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
US10550171B2 (en) 2012-11-21 2020-02-04 The Governors Of The University Of Alberta Immunomodulatory peptides and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6822082B2 (en) * 2000-06-30 2004-11-23 Zymogenetics, Inc. Polynucleotides for mammalian secreted protein, Z1055G2P
ES2286128T3 (es) * 2000-06-30 2007-12-01 Zymogenetics, Inc. Proteina zcyto21 tipo interferon.

Similar Documents

Publication Publication Date Title
US12134656B2 (en) Dickkopf-1 variant antibodies and methods of use
KR101502179B1 (ko) 전사 부정확, 검출 및 이의 용도
JP2014509853A5 (enExample)
JP2006516189A5 (enExample)
JP2005514030A5 (enExample)
WO2016077366A1 (en) Therapeutic and diagnostic methods for il-33-mediated disorders
JP2005522999A5 (enExample)
JP2004535161A5 (enExample)
JP2004513614A5 (enExample)
JP2005507648A5 (enExample)
JPH1066585A5 (enExample)
EP4667484A1 (en) Homodimeric protein combining human il-1r1 with human il-1racp polypeptide fragments and use
JP2004537284A5 (enExample)
JP2003510078A5 (enExample)
JP2012153664A (ja) 抗il28b抗体及びこれを用いたil28bの測定方法
JP2008507253A5 (enExample)
JP2004515215A5 (enExample)
CN109486824A (zh) 一种特异性结合Taq酶的核酸适配体及其筛选方法、应用
CN103360490B (zh) 一种peb致病基因新突变及其应用
CN104761630A (zh) 奶牛早孕因子蛋白、表达载体及其在奶牛早孕判断中的应用
JP2005531290A5 (enExample)
JP2005514916A5 (enExample)
JP2008509659A5 (enExample)
JP6348699B2 (ja) インターフェロン治療効果予測方法
JP2001057888A5 (enExample)